TEVA-MOMETASONE 50 MCG
MOMETASONE FUROATE : 50 MCG · DIN 02475863 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-MOMETASONE?
TEVA-MOMETASONE 50 MCG contains MOMETASONE FUROATE : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 02475863, held by TEVA CANADA LIMITED, supplied as SPRAY, METERED DOSE for NASAL administration. Health Canada currently lists it as marketed, status dated 02-Oct-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-MOMETASONE used for?
TEVA-MOMETASONE (mometasone furoate monohydrate aqueous nasal spray) is indicated for: use in children between the ages of 3 and 11 years to treat the symptoms of seasonal or perennial allergic rhinitis. use in adults and children 12 years of age and older as adjunctive treatment to antibiotics in acute episodes of rhinosinusitis, where signs or symptoms of bacterial infection are present. use in adults and children 12 years of age and older in the treatment of symptoms associated with mild to moderate uncomplicated acute rhinosinusitis where signs or symptoms of bacterial infection are not present. the treatment of nasal polyps in adult patients 18 years of age or older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02475863 |
|---|---|
| Brand name | TEVA-MOMETASONE |
| Generic / active ingredient | MOMETASONE FUROATE : 50 MCG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 50 MCG |
| Dosage form | SPRAY, METERED DOSE |
| Route of administration | NASAL |
| Schedule | Prescription |
| ATC code | R01AD09 MOMETASONE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-Oct-2018 |
| Original market date | 2019-03-27 00:00:00 |
How is it stored and handled?
between 2 and 25 °C. Do not freeze.
How is it supplied?
single pack (1 bottle)
What can be used instead?
Other Canadian products sharing ATC code R01AD09 MOMETASONE. 6 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-MOMETASONE | 50 MCG | SPRAY, METERED DOSE | APOTEX INC | MARKETED | DIN 02403587 |
| MOMETASONE | 50 MCG | SPRAY, METERED DOSE | SANIS HEALTH INC | MARKETED | DIN 02519127 |
| MOMETASONE | 50 MCG | SPRAY, METERED DOSE | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02551756 |
| NASONEX | 50 MCG | SPRAY, METERED DOSE | ORGANON CANADA INC. | MARKETED | DIN 02238465 |
| SANDOZ MOMETASONE | 50 MCG | SPRAY, METERED DOSE | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02449811 |
| MOSASPRAY | 50 MCG | SPRAY, METERED DOSE | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02455870 |
| NASAL ALLERGY AND CONGESTION RELIEF | 50 MCG | SPRAY, METERED DOSE | APOTEX INC | APPROVED | DIN 02451905 |
| NASONEX ALLERGY AND CONGESTION | 50 MCG | SPRAY, METERED DOSE | MERCK CANADA INC | CANCELLED PRE MARKET | DIN 02410524 |
Who else supplies MOMETASONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MOMETASONE appears in 2383 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.